Zhangzhou Pientzehuang Pharmaceutical. Ltd Financials

Market Capitalization CN¥132.13 Billion as of Jan. 1, 2025

Valuations Metrics as of Jan. 25, 2025

Trailing PE	43.03
Forward PE	36.32
Price to Sales TTM	CN¥12.11
Price to Book MRQ	CN¥9.42
Enterprise to Revenue	11.94
Enterprise to EBITDA	36.20

Financial Reports as of Sep. 30, 2024

Financials

Fiscal Year Ends	2023-12-31
Most Recent Quarter	2024-09-30
Profit Margin	28.23%
Operating Margin	39.49%
Return on Assets TTM	12.89%
Return on Equity TTM	22.05%

Income Statement

Revenue TTM	CN¥10,908,942,336
Revenue per Share TTM	CN¥18.07
Quarterly Revenue Growth	9.60%
Gross Profit TTM	CN¥4,703,227,700
EBITDA	CN¥3,704,971,121
Net Income to Common TTM	CN¥3,079,387,904
Diluted EPS TTM	CN¥5.09
Quarterly Earnings Growth YoY	11.70%

Balance Sheet

Total Cash MRQ	CN¥3,269,835,008
Total Cash per Share MRQ	CN¥5.42
Total Debt MRQ	CN¥
Total Debt to Equity MRQ	8.04
Current Ratio MRQ	5.12
Book Value per Share MRQ	CN¥23.24

Cash Flow

Operating Cash Flow TTM	CN¥1,125,992,320
Levered Free Cash Flow TTM	CN¥1,773,779,968

600436 Stock Info as of Jan. 25, 2025

Stock Statistics

Shares Outstanding	603,316,992
Float Shares	230,702,468
Avg 10 Volume	3,051,064
Avg 30 Volume	None
Shares Short	None
Short Ratio
Short % of Shares	%
% Held by Insiders	63.67%
% Held by Institutions	6.78%

Stock Price Summary

Beta	0.80
Fifty Two Week Low	CN¥180.69
Fifty Two Week High	CN¥284.34
Fifty Two Week Change	-11.69%
Day 50 MA	CN¥237.75
Day 200 MA	CN¥224.99

Dividends and Splits

Forward Annual Dividend Rate	CN¥4.60
Forward Annual Dividend Yield	2.29%
Trailing Annual Dividend Rate	CN¥1.15
Trailing Annual Dividend Yield	0.57%
Payout Ratio	45.49%
Dividend Date
Ex Dividend Date	2024-10-22
Last Split Factor
Last Split Date	2016-05-24